Table 1 Primary Sites
From: Utility of SUVmax on 18 F-FDG PET in detecting cervical nodal metastases
Primary site | Frequency | Percent |
|---|---|---|
Oral cavity | 43 | 58.1 |
Larynx | 13 | 17.6 |
Cutaneous | 10 | 13.5 |
UNPHNC | 5 | 6.8 |
Hypopharynx | 3 | 4.1 |
Total | 74 | 100 |
From: Utility of SUVmax on 18 F-FDG PET in detecting cervical nodal metastases
Primary site | Frequency | Percent |
|---|---|---|
Oral cavity | 43 | 58.1 |
Larynx | 13 | 17.6 |
Cutaneous | 10 | 13.5 |
UNPHNC | 5 | 6.8 |
Hypopharynx | 3 | 4.1 |
Total | 74 | 100 |